Quantcast
Home > Quotes > BIIB
BIIB

Biogen Inc. Common Stock (BIIB) Quote & Summary Data

$319.21
*  
4.84
1.49%
Get BIIB Alerts
*Delayed - data as of Nov. 19, 2018  -  Find a broker to begin trading BIIB now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    BIIB Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
394
Today's High / Low
$ 326.32 / $ 315.45
Share Volume
1,203,875
50 Day Avg. Daily Volume
1,333,700
Previous Close
$ 324.05
52 Week High / Low
$ 388.67 / $ 249.17
Market Cap
64,315,259,150
P/E Ratio
20.63
Forward P/E (1y)
12.38
Earnings Per Share (EPS)
$ 15.47
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.99

Intraday Chart

Shares Traded

Share Volume:
1,203,875
50 Day Avg. Daily Volume:
1,333,700

P/E Ratio

P/E Ratio:
20.63
Forward P/E (1y):
12.38
Earnings Per Share (EPS):
$ 15.47

Trading Range

The current last sale of $319.21 is 28.11% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 326.32 $ 388.67
 Low: $ 315.45 $ 249.17

ETFs with BIIB as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
8.49% iShares Nasdaq Biotechnology Index Fund (IBB) -5.15 (-4.77%)
5.4% Invesco Dynamic Biotech & Genome ETF (PBE) -4.03 (-7.49%)
5.21% VanEck Vectors Biotech ETF (BBH) -0.56 (-0.48%)
3.58% First Trust Amex Biotech Index Fund (FBT) -5.00 (-3.64%)
3.36% Virtus LifeSci Biotech Products ETF (BBP) -6.76 (-15.68%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Biogen is a global biopharmaceutical company focused on discovering, developing and delivering worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases, including in our core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement disorders and neuromuscular disorders, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). We also plan to invest in emerging growth areas such as pain, ophthalmology, neuropsychiatry and acute neurology. In addition, we are employing innovative technologies to discover potential treatments for rare and genetic disorders, including new ways of treating diseases through gene therapy in the previously mentioned areas. We also manufacture and commercialize biosimilars of advanced biologics.  ... More ...  


Risk Grade

Where does BIIB fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 325.12
Open Date:
Nov. 19, 2018
Close Price:
$ 319.21
Close Date:
Nov. 19, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x